Skip to main content

Market Overview

38 Stocks Moving In Tuesday's Mid-Day Session



  • Arsanis Inc (NASDAQ: ASNS) shares jumped 68 percent to $1.9490 after the company announced a merger agreement with X4 Pharma.
  • Aethlon Medical, Inc. (NASDAQ: AEMD) jumped 24 percent to $1.45 after the company's cancer therapy received Breakthrough Device designation from the FDA.
  • Sphere 3D Corp. (NASDAQ: ANY) shares gained 23.4 percent to $7.5283.
  • AgEagle Aerial Systems, Inc. (NASDAQ: UAVS) gained 22.2 percent to $0.8854 as the company issued press release highlighting the signing of a significant crop producer and supplier in North America to its sustainability and drone-leasing program.
  • CohBar, Inc. (NASDAQ: CWBR) shares rose 21.2 percent to $3.72.
  • Spirit Airlines, Inc. (NYSE: SAVE) climbed 19.8 percent to $61.0950 after the company raised Q4 TRASM and CASM guidance.
  • Cocrystal Pharma, Inc. (NASDAQ: COCP) gained 19.3 percent to $3.40.
  • BSB Bancorp, Inc. (NASDAQ: BLMT) rose 15.8 percent to $31.10 after the company was acquired by People's United Financial.
  • Frontline Ltd. (NYSE: FRO) shares rose 14.6 percent to $7.30.
  • StoneCo Ltd. (NASDAQ: STNE) rose 14.3 percent to $24.800 after reporting Q3 results.
  • Zymeworks Inc. (NASDAQ: ZYME) gained 13.9 percent to $13.07. Zymeworks and BeiGene reported license and collaboration agreement for Zymeworks' HER2-targeted therapeutic candidates, ZW25 And ZW49, in Asia-Pacific, and research and license agreement for Zymeworks' Azymetric and EFECT platforms globally.
  • LAIX Inc. (NYSE: LAIX) rose 10.3 percent to $9.10 following Q3 results.
  • DHT Holdings, Inc. (NYSE: DHT) shares surged 10.2 percent to $4.695.
  • SunOpta Inc. (NASDAQ: STKL) gained 9.7 percent to $4.76.
  • Addus Homecare Corporation (NASDAQ: ADUS) rose 9.2 percent to $74.69 following news the stock will replace CACI in the S&P SmallCap 600. CACI will be joining the S&P 500.
  • LINE Corporation (NYSE: LN) gained 8.7 percent to $33.54.
  • Innovative Industrial Properties, Inc. (NYSE: IIPR) rose 8.3 percent to $50.63.
  • Eyenovia, Inc. (NASDAQ: EYEN) climbed 8 percent to $3.13. Eyenovia said it has enrolled the first patient in the first of two Phase 3 trials, dubbed MIST-1, for its MicroStat program for pharmacologic mydriasis, or dilation of the pupil for an eye exam.
  • Maxim Integrated Products Inc. (NASDAQ: MXIM) rose 4.1 percent to $55.57 amid news the stock will be joining the S&P 500 index.


Check out these big penny stock gainers and losers


  • Ferroglobe PLC (NASDAQ: GSM) shares dipped 53.8 percent to $2.2050 after the company reported weaker-than-expected results for its third quarter.
  • Francesca's Holdings Corp (NASDAQ: FRAN) fell 17.7 percent to $1.9001 after the company issued a weak forecast for the third quarter.
  • G1 Therapeutics Inc (NASDAQ: GTHX) fell 16.6 percent to $33.30 following Phase 2 data for trilaciclib in combo with chemo/Tecentriq which showed statistically significant improvements in primary endpoints but no statistical difference in candidate vs placebo groups.
  • MICT, Inc. (NASDAQ: MICT) dipped 15 percent to $0.4101 after the company reported Q3 EPS of $(0.28) down $0.12 from Q3 last year, with sales down around 68% year over year to $2.216 million.
  • FTE Networks, Inc. (NASDAQ: FTNW) shares dipped 13.7 percent to $3.4763.
  • Alta Mesa Resources, Inc. (NASDAQ: AMR) dropped 12 percent to $1.83.
  • Therapix Biosciences Ltd. (NASDAQ: TRPX) shares fell 11.6 percent to $6.162. Therapix Biosciences issued $1,500,000 convertible debentures.
  • Cubic Corporation (NYSE: CUB) shares dropped 9.9 percent to $59.670 after reporting a proposed public offering of common stock.
  • VIVUS, Inc. (NASDAQ: VVUS) dipped 9.7 percent to $2.62.
  • ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) shares fell 9.6 percent to $17.58 following announcement of $200 million common stock offering.
  • Amarin Corporation plc (NASDAQ: AMRN) shares fell 9.3 percent to $17.5800 after the company priced a public offering of common stock for gross proceeds of $200 million.
  • Halozyme Therapeutics, Inc. (NASDAQ: HALO) fell 8.2 percent to $15.35 as company adjusted the qualification for its endpoint of its HALO-301 trial to a single primary endpoint of overall survival.
  • Urban One, Inc. (NASDAQ: UONE) shares fell 7.8 percent to $2.13.
  • Proteostasis Therapeutics, Inc. (NASDAQ: PTI) dropped 7.7 percent to $5.07.
  • AK Steel Holding Corporation (NYSE: AKS) fell 7.3 percent to $3.03 after dropping 4.11 percent on Monday.
  • Auris Medical Holding AG (NASDAQ: EARS) dropped 6.7 percent to $0.628. Auris Medical filed for an offering of up to 1.75 million shares of common stock by Lincoln Park Capital.
  • Buckle Inc (NYSE: BKE) fell 6.4 percent to $19.555 after the company reported downbeat results for its third quarter on Monday.
  • Bristol-Myers Squibb Co (NYSE: BMY) fell 5 percent to $50.10 as company reported its CheckMate -451 study did not meet its primary endpoint.
  • Canada Goose Holdings Inc. (NASDAQ: GOOS) dropped 4 percent to $63.745 after the company announced a 10 million share offering by certain shareholders including executives and directors.

Related Articles (ACAD + ADUS)

View Comments and Join the Discussion!

Posted-In: LosersNews Movers & Shakers Intraday Update Markets Movers Trading Ideas General

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at